| Financial Year |
March 31 2023 |
| Monetary Funds |
413,834,555.89 |
| Held-for-trading Financial Assets |
522,363,245.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
54,754,212.50 |
| Advances to Suppliers |
27,284,659.17 |
| Other Receivables |
25,409,428.96 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
10,179,737.79 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
338,736,979.80 |
| Total Current Assets |
1,656,568,989.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
692,567,896.48 |
| Under-construction Projects |
869,474,563.93 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
1,699,333,831.78 |
| Intangible Assets |
2,356,098,008.46 |
| R&D expenses |
-- |
| Goodwill |
396,178,329.78 |
| Long-Term Deferred and Prepaid Expenses |
18,417,339.17 |
| Deferred Income Tax Assets |
6,218,970.01 |
| Other Non-Current Assets |
65,052,366.22 |
| Sub-Total of Non-Current Assets |
6,136,064,085.22 |
| Total Assets |
7,792,633,074.88 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
128,788,598.77 |
| Accounts Payable |
21,503,568.88 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,335,647.12 |
| Taxes Payable |
12,973,120.55 |
| Interest Payable |
-- |
| Dividend Payable |
83,511,077.84 |
| Other payables |
408,920,753.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
446,804,913.99 |
| Other Current Liabilities |
1,645,256.26 |
| Sub-Total of Current Liabilities |
1,126,825,929.98 |
| Long-term Loans |
448,281,048.00 |
| Bonds Payable |
1,275,530,525.78 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
14,565,846.58 |
| Deferred Income Tax Liabilities |
382,775,782.33 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,157,035,073.02 |
| Total Liabilities |
3,283,861,003.00 |
| Paid-In Capital(Or Share Stock) |
268,535,449.00 |
| Capital Surplus |
2,130,445,053.90 |
| Surplus Reserve |
15,544,839.06 |
| LESS:Treasury Stock |
55,140,269.00 |
| Undistributed Profits |
422,548,925.49 |
| Minority Stockholder's Interest |
1,565,376,994.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,943,395,077.00 |
| Owner's Equity（Stockholder's Equity） |
4,508,772,071.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,792,633,074.88 |
